Name: Diagnostic, Prognostic, and Therapeutic Role of Micrornas in Head and Neck Cancer (en Inglés)
SKU: 63295000
Price: 3155.60 MXN
Availability: InStock
Author: Kumar Ashok,Arya Neha,Tiwari Shikha
ISBN: 9780443159688

portada Diagnostic, Prognostic, and Therapeutic Role of Micrornas in Head and Neck Cancer (en Inglés)

Diagnostic, Prognostic, and Therapeutic Role of Micrornas in Head and Neck Cancer (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Kumar Ashok,Arya Neha,Tiwari Shikha

Idioma

Inglés

N° páginas

362

Encuadernación

Tapa Blanda

ISBN13

9780443159688

N° edición

Diagnostic, Prognostic, and Therapeutic Role of Micrornas in Head and Neck Cancer (en Inglés)

Kumar Ashok,Arya Neha,Tiwari Shikha (Autor) · Academic Press · Tapa Blanda

Libro Nuevo Importado

Envío: 19 a 25 días háb.

$ 5,737.45$ 3,155.60

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 3,155.60

¡Envío Gratis! Llega entre el 23 Nov y el 02 Dic a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Diagnostic, Prognostic, and Therapeutic Role of Micrornas in Head and Neck Cancer (en Inglés)"

Diagnostic, Prognostic and Therapeutic Role of MicroRNAs in Head and Neck Cancer provides detailed information on various miRNA-based approaches for the diagnosis, prognosis, and treatment of HNSCC. The book encompasses various miRNA-based point-of-care diagnostics and drug delivery systems for HNSCC, along with information on clinical trials for improved clinical outcomes in HNSCC patients. In addition, it provides a comprehensive overview of currently available miRNAs associated with HNSCC and their extensive application for early diagnosis, prognosis, and treatment. Scientists and clinicians looking to win the battle against HNSCC will benefit from the book's sections on early diagnosis to improve treatment, increase treatment response rates, and reduce mortality rates. Recently, miRNA-based diagnostics and therapeutics have gained considerable attention among the scientific community. MiRNAs are known to have great potential as biomarkers for early diagnosis, prediction, and prognosis of HNSCC, and play a role in development of targeted gene therapy.